Lp(a) measurement

Summary

• An Lp(a) concentration of ≥50 mg/dL (≥100/125 nmol/L) is widely considered to be elevated
• Most currently available Lp(a) assays can be used for cardiovascular (CV) risk stratification
• International guidelines recommend Lp(a) measurement at least once in adult life

Please login or create a FREE account to view this content

Email Address*

Password*

Only fill in if you are not human

Keep me signed in

Register

Forgot your password?

See more articles in our Back to Basics series

• What is Lp(a)?
• Lp(a) and cardiovascular disease
• Lp(a) and current lipid lowering therapies
• Why test Lp(a)?

Back to Basics slide deck available now

Analyse the underlying determinants of elevated Lp(a) through our comprehensive slide deck covering non-modifiable variables—such as genetics, ethnicity, and menopause—alongside modifiable secondary factors including renal and thyroid pathologies.

And watch a video commentary from Dr Jaimini Cegla, where she addresses key inquiries surrounding the risk factors for elevated Lp(a). She evaluates the robustness of current clinical evidence and examines how high Lp(a) levels impact cardiovascular risk management and day-to-day patient care in clinical practice.